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Abstract
Background: Crimean-Congo hemorrhagic fever (CCHF) activity has recently been detected in the Kordufan region of
Sudan. Since 2008, several sporadic cases and nosocomial outbreaks associated with high case-fatality have been reported
in villages and rural hospitals in the region.
Principal Findings: In the present study, we describe a cluster of cases occurring in June 2009 in Dunkop village, Abyei
District, South Kordufan, Sudan. Seven CCHF cases were involved in the outbreak; however, clinical specimens could be
collected from only two patients, both of whom were confirmed as acute CCHF cases using CCHF-specific reverse
transcriptase polymerase chain reaction (RT-PCR). Phylogenetic analysis of the complete S, M, and L segment sequences
places the Abyei strain of CCHF virus in Group III, a virus group containing strains from various countries across Africa,
including Sudan, South Africa, Mauritania, and Nigeria. The Abyei strain detected in 2009 is genetically distinct from the
recently described 2008 Sudanese CCHF virus strains (Al-fulah 3 and 4), and the Abyei strain S and L segments closely match
those of CCHF virus strain ArD39554 from Mauritania.
Conclusions: The present investigation illustrates that multiple CCHF virus lineages are circulating in the Kordufan region of
Sudan and are associated with recent outbreaks of the disease occurring during 2008–2009.
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Introduction
Crimean-Congo hemorrhagic fever (CCHF), caused by Crimean-
Congo hemorrhagic fever virus (CCHFV), is a tick-borne virus with a
tripartite RNA genome (segments designated S, M, and L). CCHFV
can be transmitted to humans by the bite of an Ixodid tick and by
contact with blood or tissue from infected livestock and humans [1–3].
CCHFV has been detected in a broad geographic zone including
much of Africa, southern Europe and Asia, extending from western
China to the Middle East and Southern Russia, where focal
endemic areas have been identified [1,4–13]. Disease outbreaks and
sporadic cases of CCHF have been recorded throughout these
endemicareas, with severalrecent outbreaksoccurring inthe Sudan
[14]. In 2008, a nosocomial outbreak of CCHF occurred in a rural
hospital in the Al-fulah District, Western Kordufan, Sudan [14];
two minor genetic variants, designated Al-fulah 3 and 4 (Genbank
Q862371-2), were identified during that outbreak and were thought
to be responsible for the emergence of the disease in the region.
We conducted the present study to analyze a June 2009 disease
cluster involving approximately seven suspect cases of CCHF in
Dunkop village, Abyei District, South Kordufan, Sudan. This
represents the second CCHF outbreak reported in Sudan’s Kordufan
region last year. Although clinical samples could only be collected for
two of the cases involved in the June outbreak, both cases were
laboratory confirmed as acute CCHF by reverse transcription
polymerase chain reaction (RT-PCR) targeting the viral nucleopro-
tein (NP) of the S segment, which is one of the least variable areas of
the genome [15]. Genetic analysis of virus from one case-patient
demonstrated that the virus strain belonged to Group III – a virus
lineage associated with strains found in Sudan, South Africa,
Mauritania, and Nigeria. However, additional analysis revealed that
the virus strain implicated in the June 2009 cluster was genetically
distinct from that involved in the 2008 Al-fulah outbreak.
Materials and Methods
Hemorrhagic Fever Case Definition
The case definition used for identification of suspect hemor-
rhagic fever patients included onset of fever and one or more of
the following symptoms: hemorrhagic manifestations (ecchymosis,
www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1159petechia, epistaxis, hematemesis), bloody diarrhea, severe head-
ache, joint pain, chills, headache, and nausea.
Sample Collection and Preparation
Blood samples were collected from two acute hemorrhagic fever
(HF) patients in clean, sterile vacutainers. Samples were collected
as part of routine diagnostic testing during outbreak response.
Ethical clearance was obtained from the Ministry of Health of
Sudan and informed consent from all patients was provided
through an ethical clearance form which permitted use of the
samples for diagnostic and research purposes. In addition to being
used for routine malaria screening, blood was allowed to clot, and
sera were separated and sent to the Division of Virology, National
Medical Health Laboratory, Khartoum, Sudan, for diagnostic
screening. Aliquots of serum samples were shipped frozen in Trizol
buffer at a ratio of 1:5 to the Viral Special Pathogens Branch, U.S.
Centers for Disease Control and Prevention, Atlanta, GA for viral
RNA extraction and subsequent sequencing of the whole virus
genome.
Virus Isolation and Serology
Due to the hazards associated with cultivation of CCHFV (the
presumptive cause of disease), virus isolation attempts were not
conducted in Sudan, and regulations prevented shipment of the
infectious clinical samples to CDC’s high-containment facility in
Atlanta. Therefore, identification of the virus was solely
dependent on serology and RT-PCR amplification, using primers
targeting the S segment of the Al-fulah strain of CCHFV
(Genbank accession number GQ862371), followed by direct
sequencing.
Serologic tests were conducted in Sudan to screen the sera for
antibodies to yellow fever and dengue fever using kits provided by
NAMRU3, Cairo, Egypt. Rift Valley fever and CCHF virus
antibody testing in Sudan was done using ELISA kits from
Biological Diagnostic Supplies Limited (South Africa). Screening
was performed using either IgM enzyme-linked immunosorbent
assays or indirect immunofluorescence assays (IIFT).
Molecular Diagnostic Testing
Viral RNA was extracted from the patient’s serum samples
either using QIAamp viral RNA kit (QIAamp, GmHb, Germany)
or Qiagen’s RNeasy kit as per manufacturer’s instructions. The
nucleoprotein gene was targeted, using a pair of primers designed
based on alignments of nucleotide sequences of Al-fulah strain
(Genbank accession number GQ862371) with several CCHFV
strains using BioEidit software (Carlsbad, CA, USA). The forward
primer CCHF1 (59-ATA CGA GTG TGC ATG GGT CA-39)
included bases 286–305 of the positive sense strand of the virus S
segment, whereas the reverse primer CCHF2 (59-TTT GCA ATG
TGC TTG AGG AG -39) included bases 892-912 of the negative
sense strand. Use of primers CCHF1 and CCHF2 in an RT-PCR
produced a 627-bp primary PCR product. All primers were
synthesized on a DNA synthesizer (Milliigen/Biosearch, a division
of MilliporeBurlington, MA, USA) and purified using oligo-pak
oligonucleotide purification columns (Glen Research Corporation,
Sterling, VA, USA.) as per manufacturer’s instructions.
Five microliters of extracted RNAs were employed in RT-PCR
assays to detect the CCHF viral genome using primers either
described in this study or by Schwartz et al [16]. The RNA
specimens were also submitted to the Molecular Biology
Laboratory of the Faculty of Veterinary Medicine, University of
Khartoum, and the Faculty of Medical Laboratory Sciences, the
National Ribat University, Sudan, for further confirmation of the
results by RT-PCR as described by Schwartz et al [16]. Additional
suspected hemorrhagic fever viruses including Rift Valley fever
and yellow fever were ruled out by RT-PCR using previously
described assays [17]. Detection of dengue virus serotypes was
carried out using Geno-Sen’s DENGUE 1–4 Real Time PCR Kit
following the manufacturer’s instructions (Genome Diagnostic Pvt.
Ltd, India).
Virus Complete Genome Sequencing
Sequences of the virus S, M, and L genome RNA segments
were generated as previously described [15]. Viral RNA extracted
from serum was used for RT-PCR amplification of all three
segments for one patient from the Abyei outbreak (Genbank
HQ378179, HQ378183, HQ378187). Additionally, sequences of
two complete and one partial M segments (Genbank HQ378184-
6) and three complete L segments (Genbank HQ378180-2) were
generated from viruses detected in patient sera obtained from the
previously reported Sudanese Al-fulah outbreak in 2008 [14].
Phylogenetic Analysis
SeqView was used to align complete S, M, and L segment
sequences for all CCHFV strains available in GenBank, as well as
the sequences obtained from Abyei 1–2009 and Al-fulah 1, 2, 3, 4,
6, 7, 8, and 9–2008 virus strains. Maximum likelihood analysis was
conducted for each segment using default settings in GARLI
(v0.96b8)[18]. Bootstrap support values were created from 1,000
replicates, and 50% majority rule trees were generated for each of
the segments. CCHFV strains are represented by their country of
origin, strain name, and date of collection when available.
Results
Seven patients suspected of HF illness near Abyei
District, Sudan
During June 2009, seven patients meeting the hemorrhagic
fever (HF) case definition were identified from Dunkop village.
Dunkop village is located 15 kilometers to the east of Abyei in the
former state of Western Kordufan, Sudan, an area that is shared in
part by the government of South Sudan and the government of
Author Summary
The tick-borne virus which causes the disease Crimean-
Congo hemorrhagic fever (CCHF) is known to be widely
distributed throughout much of Africa, Southern Europe,
the Middle East, Central Asia, and Southern Russia.
Humans contract the virus from contact with infected
people, infected animals (which do not show symptoms),
and from the bite of infected ticks. CCHF was recently
recognized in the Sudan when several hospital staff and
patients died from the disease in a rural hospital. The
genetic analysis of viruses associated with the 2008 and
2009 outbreaks shows that several CCHF viral strains
currently circulate and cause human outbreaks in the
Sudan, highlighting CCHF virus as an emerging pathogen.
The Sudanese strains are similar to others circulating in
Africa, indicating movement of virus over large distances
with introduction and disease outbreaks in rural areas
possible. Understanding the epidemiology of zoonotic
diseases such as CCHF is especially important in the Sudan
given the large numbers of livestock in the country, and
their importance to the economy and rural communities. It
is imperative that hospital staff consider CCHF as a
possible disease agent, since they are at a high risk of
contracting the disease, especially in hospitals with limited
medical supplies.
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the nomadic Arab tribes of Misariya from the north and the
Nilotic tribes of Dinka from the south. Transport from Dunkop
village to the hospital in Abyei town is extremely difficult, if not
impossible, during the rainy season, which includes the month of
June. When passable, the distance between the primary-care
centers and the surrounding villages is usually crossed by walking;
therefore, evacuation of suspect cases from Dunkop village to
Abyei hospital was not possible for all patients due to poor road
conditions and prevailing insecurity at the time. Of the five
patients able to travel to Abyei hospital, two died and one was
discharged before samples could be collected for laboratory
testing. Given the proximity of approximately 250 kilometers
from Al-fulah (Figure 1), the location of a nosocomial outbreak of
CCHF in October 2008, CCHF was considered as a possible
cause of the HF illness [14]. Blood samples were available from
two patients with signs of acute HF illness. The extracted RNA
samples were used in RT-PCR as targets for CCHF definitive
diagnosis and subsequent sequencing.
Limited epidemiologic and clinical details were obtained where
possible from interviews with patients or close relatives, or from
hospital records (Table 1). The age range of the seven patients
suspected of having CCHF was 21–65 years. Five of the suspect
patients were female (all housewives), and the last two were male (a
student and a day laborer). Traditionally, the activities of women in
these rural villages include shepherding livestock and milking of
cows, and both the index case and one of the confirmed cases
specifically reported animal contact. The potential for exposure to
viremic livestock or virus infected ticks would be considered high.
No evidence of nosocomial transmission was apparent based on the
lack of any reports of infections with compatible illness among
healthcareworkerspotentiallyexposed tothesecases.Allcaseswere
from the same small village, and although there were reports of
contact between several of the cases, no strong evidence of a clear
chain of transmission could be discerned based on the limited data
available. Contact transmission cannot be ruled out however, as the
dates for onset of symptoms ranged over a 6 day period from June
12
th through 18
th 2009, allowing for the possibility of later cases
having acquired the infection from the earliest cases identified.
Symptoms and clinical signs of the disease among the seven
suspected patients, included rapid onset of fever (common to all
suspected patients), and some or all of the following symptoms:
headache; nausea; vomiting (with or without blood); severe muscle,
joint, and/or chest pain; agitation; diarrhea; bleeding from the
nostrils, mouth, gum, and upper and lower gastrointestinal tracts.
Four of the seven cases progressed to coma and fatal outcome.
Two case-patients tested positive for CCHF by RT-PCR
Serologic tests on sera from two suspected HF patients were
negative for yellow fever, dengue fever, West Nile fever, and Rift
Valley fever, as determined by either IgM enzyme-linked immuno-
sorbent assay (ELISA) or indirect immunofluorescence assay (IIFT).
Sera from these patients also tested negative for the presence of
CCHF antibodies, as is common in fatal CCHF cases when sera is
drawn 1–3 days post onset of illness. A second blood sample was not
available from the surviving patient for further serological testing
despite having been hospitalized for 2 days before discharge.
RT-PCR assays of RNAs extracted from sera of suspected HF
patients were negative for Rift Valley fever, yellow fever, and
dengue viruses; however, conventional RT-PCR resulted in
amplification of a 627-bp PCR product specific for the CCHFV
S segment (data not shown). The two RNA specimens were
Table 1. Suspect hemorrhagic fever case characteristics.
Patient
Number Age Occupation Sex CCHF RT-PCR
Date Symptom
Onset Date of Death Symptoms
1 40 housewife F ns 6/13/2009 6/15/2009 fever, headache, nausea, agitation,
vomiting blood
2 55 housewife F ns 6/12/2009 6/15/2009 fever, diarrhea, bleeding from nostrils
3 44 housewife F ns 6/14/2009 survived fever, diarrhea, bleeding from nostrils
4 30 housewife F ns 6/14/2009 survived fever, diarrhea, bleeding from nostrils
5 65 housewife F ns 6/15/2009 6/20/2009 fever, headache, swollen joints, chest
pain, agitation, dysentery, vomiting
blood, bleeding from nostrils, GI
bleeding, bleeding from mouth, coma
6 21 student M Positive 6/15/2009 6/21/2009 fever, headache, nausea, agitation,
vomiting blood
7 35 day laborer M Positive 6/18/2009 survived fever, headache, nausea, vomiting,




Table 2. Genbank accession numbers for Sudanese CCHF
strains.
Sample Name S M L
Al-fulah 1 Full GQ862371
Al-fulah 2 Full GQ862371
Al-fulah 3 (reference) Full GQ862371 Full HQ378184 Full HQ378180
Al-fulah 4 Full GQ862372 Partial (,4k b )
HQ378186
Full HQ378181
Al-fulah 6 Full GQ862371
Al-fulah 7 Full GQ862371
Al-fulah 8 Full GQ862371
Al-fulah 9 Full GQ862371 Full HQ378185 Full HQ378182
Abyei 1 (reference) Full HQ378179 Full HQ378187 Full HQ378183
doi:10.1371/journal.pntd.0001159.t002
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of Khartoum and the National Ribat University, and were
confirmed as CCHF cases by RT-PCR using the same primers
described in this study and CCHF primers described by Schwartz
et al [16] (data not shown). In addition, blood smears were
obtained for malaria testing at Abyei hospital, and both were
positive. The finding of positive malaria smears is not uncommon
in this area of rural Sudan and the clinical significance of the
finding in these cases was difficult to evaluate.
CCHF virus strain detected in Abyei in 2009 belongs to
Group III
Using the method reported earlier [15], whole CCHF virus
genome (S, M and L RNA segments) sequencing was attempted
for each of the CCHF virus PCR positive specimens collected from
the June 2009 Abyei outbreak and those from the earlier Al-fulah
CCHF outbreak [14]. The complete sequence of the virus S, M
and L genomic segments was successfully obtained for one sample
from the Abyei outbreak, and two complete and one partial M
segments, and two full L segments were generated from the earlier
Al-fulah specimens (Table 2).
Comparison of the virus sequences detected in the 2008 Al-
fulah outbreak revealed that few mutations occurred in any of the
three segments. Only one nucleotide difference was found among
the virus S segments; both the partial Al-fulah 4-2008 and
complete Al-fulah 9-2008 M segment sequences had one base
change when compared to the reference Al-fulah 3–2008
sequence. The complete L segment sequences for viruses Al-fulah
Figure 2. Phylogenetic relationship of Crimean-Congo hemorrhagic fever virus full length S segments. Phylogenetic relationship of the
S segment sequence of the CCHF virus Abyei and Al-fulah strains relative to previously published sequences was carried out using GARLI (v0.96b8)
[18], with default settings to generate a maximum likelihood tree with bootstrap support values from 1000 replicates. The 50% majority rule tree is
depicted. Each strain is listed by its location, strain name, and year of isolation when available with the Sudanese strains bolded.
doi:10.1371/journal.pntd.0001159.g002
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respectively, when compared to Al-fulah 3–2008. These results
indicated circulation of identical or near-identical virus variants
within the outbreak, consistent with the report of most of these
cases being linked by nosocomial transmission [14].
Phylogenetic analysis of the virus sequences derived from the
Abyei outbreak samples demonstrated that this outbreak was also
caused by a virus belonging to Group III [15].
Multiple strains of CCHF have been circulating in Sudan
in recent years
While viruses from the Al-fulah 2008 and Abyei 2009 outbreaks
are both located in Group III, the Abyei strain was genetically
distinct from the Al-fulah strain (Figures 2, 3, and 4). The two
Sudanese strains both displayed closer genetic relationships with
other Group III viruses from elsewhere in Africa than with one
another. The S and L segments of the Abyei strain matched most
closely with those of the Group III Mauritanian virus strain
ArD39554 (Figures 2 & 4). This virus had been shown previously
to be an M segment reassortant virus with the virus M segment
being the sole representative of a highly unique Group VII
[15,19]. The M segment of the Abyei strain matched another
Group III virus, namely the Nigerian IbAr10200 strain, consistent
with the Abyei virus not being a reassortant (Figure 3). The Al-
fulah strain genome segments matched most closely to other
Group III viruses from South Africa. No evidence of reassortment
Figure 3. Phylogenetic relationship of Crimean-Congo hemorrhagic fever virus full length M segments. Phylogenetic relationship of the
M segment sequence of the CCHF virus Abyei and Al-fulah strains relative to previously published sequences was carried out using GARLI (v0.96b8)
[18], with default settings to generate a maximum likelihood tree with bootstrap support values from 1000 replicates. The 50% majority rule tree is
depicted. Each strain is listed by its location, strain name, and year of isolation when available with the Sudanese strains bolded.
doi:10.1371/journal.pntd.0001159.g003
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strains [9,13,20–21].
Discussion
In Sudan, sero-epidemiological surveys conducted over the past
few decades have suggested the presence of various arboviruses in
human populations [22–23]. In addition, CCHFV specific
antibodies have been detected in camels in Egypt, and in sheep
and goats in Jeddah, Saudi Arabia, all of which had been imported
to these countries from Sudan [24–25].
Recently, CCHFV activities have been reported in the
Kordufan region of Sudan. Several suspected sporadic cases and
small outbreaks of CCHF associated with high case-fatalities were
reported in rural hospitals from October 2008 through June 2009.
CCHF was first confirmed to be present in Sudan during the 2008
nosocomial outbreak in a rural hospital in Al-fulah, Western
Kordufan [14]. During the Al-fulah outbreak, the initial treatment
in the hospital focused primarily on malaria, as blood smears from
some of the CCHF suspect patients were positive for malaria. Both
Plasmodium falciparum and P. vivax are found in Sudan, and
malaria is endemic in Kordufan region, with the transmission
Figure 4. Phylogenetic relationship of Crimean-Congo hemorrhagic fever virus full length L segments. Phylogenetic relationship of the
L segment sequence of the CCHF virus Abyei and Al-fulah strains relative to previously published sequences was carried out using GARLI (v0.96b8)
[18], with default settings to generate a maximum likelihood tree with bootstrap support values from 1000 replicates. The 50% majority rule tree is
depicted. Each strain is listed by its location, strain name, and year of isolation when available with the Sudanese strains bolded.
doi:10.1371/journal.pntd.0001159.g004
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Given how common positive smears are in this locale, it is difficult
to assess the clinical significance of the positive smears reported in
these two lab confirmed CCHF cases, particularly in the absence
of identification of Plasmodium species involved. While specula-
tive, it is possible that the immunosuppression associated with
CCHFV infections [28] might facilitate malaria recurrence and
invasion of malaria parasites from the liver to the blood stream.
Our point is that the finding of a malaria positive smear should not
be basis of cessation of testing for other etiologies which pose a risk
of nosocomial transmission to the medical staff, as fever of
unknown origin can also indicate viral hemorrhagic fever (VHF) in
endemic countries like Sudan [14]. In this outbreak, serum
samples from the patients were also tested for CCHF which led to
the identification of etiology of the disease outbreak.
Transmission of CCHFV in the recent Sudanese outbreaks
likely involved either tick-bites or person-to-person spread. Tick
bite transmission or exposure to blood or tissues of infected
livestock is more likely to occur during rainy months, when roads
become very muddy and transport between villages or cities,
becomes extremely difficult. In these conditions, the local residents
typically live in close contact with their cattle within their home
villages, increasing the risk of acquiring infection from infected
livestock or by tick bite. Once CCHF cases are admitted to
medical facilities, nosocomial chains of transmission can occur
within hospitals and clinics lacking resources or training to fully
implement universal barrier nursing conditions and effective
infection control practices [29–30]. This was clearly the case in
the Al-fulah 2008 outbreak [14].
The genetic diversity of CCHFV, its virulence, and its potential
as a bioterrorism agent underscore the importance of genetic
characterization of virus strains from all geographically distinct
endemic areas. This type of analysis improves the design and
development of rapid diagnostics and potential candidate vaccines
for this devastating disease.
This investigation expands on existing data indicating that
Group III CCHFV lineage, known to be endemic in Sudan, South
Africa, Mauritania, and Nigeria, is broadly distributed within
Africa. Furthermore, our study illustrates that multiple strains
belonging to Group III virus lineage from the African continent
are currently present in the Sudan and are responsible for the
recent outbreaks of the disease in the Kordufan region. The
genetic linkage of the recent Sudan outbreak viruses would be
compatible with viruses having been introduced to Sudan from
South Africa, Senegal, Mauritania or Nigeria as a result of the
international trade of livestock or by bird migration. However, as
the Sudan is the largest country in Africa and the richest in animal
resources, it seems unlikely to import livestock and associated
products from these distant regions of Africa. Phylogenetic study of
the sequence diversity of all the characterized CCHFV strains
clearly indicates that virus genetic lineages are not precisely
restricted to defined geographic locations, but considerable
movement of viruses is occurring over long distances. These data
would suggest that the role of bird migration in disease
transmission should strongly be considered in the dissemination
of CCHFV.
The occurrence of multiple CCHF outbreaks in Sudan in the
past few years, and the risks these cases pose for medical staff in
resource poor health care facilities indicate the importance of
improved surveillance in Sudan for this important disease. The
attending physicians, working in those areas of endemicity, should
consider this virus in their efforts to diagnose the disease in patients
presented to hospitals or clinical centers with symptoms indicative
of HF.
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